Data as an Asset: Utilizing data in the health and life sciences industry

Utilizing health data requires health and life sciences companies to tread a fine line between innovation and protecting patient privacy. Listen to the latest episode in our Data as an Asset podcast series, where we outline: key US, EU and UK regulations global health and life sciences companies need to be aware of,  the obstacles and opportunities for research, product development, patients and the public good and AI's potential for healthcare innovation